Clinical and functional state of the retina after inadequate laser coagulation of peripheral vitreochorioretinal dystrophies. Part 1. Electroretinography

Purpose of our work was to evaluate the effect of inadequate laser coagulation (LC) of peripheral vitreochorioretinal dystrophy (PVCRD) on the clinical and functional state of the retina. Material and methods. Ganzfeld ERG and multifocal ERG (mfERG) were recorded in 18 patients (32 eyes) with PVСRD in which, upon examination of the fundus, signs of inadequate retinal LC were detected and documented, such as hypercoagulation, an excessively large number of coagulates with minimal changes in the retina, or massive LC at the normal fundus. Results. The functional activity of the macular region after massive LC at the periphery of the retina in patients with PVCRD was shown to be reduced. The characteristic signs of reduction of the ganzfeld ERG and mfERG associated with a large volume of LC of the retina in patients without a history of surgical treatment of rhegmatogenous retinal detachment are described. For the first time, a functional method has been proposed to identify the risk of development and progression of macular dysfunction associated with massive LC of the retina, which includes a decrease in the amplitude of the waves of the maximal ERG and / or oscillatory potentials by 30 % or more with a parallel decrease in the density P1 in 1–3 rings of mfERG by 30 % and more as compared to the norm. Conclusion. Electrophysiological markers of macular dysfunction development risk associated with massive LC of the retina are proposed. The use of these markers in the clinic is important for predicting the risk of pathological changes in the macular region involving a decrease in visual functions, the choice of treatment tactics, and expert assessment of the volume of retinal LC redundancy.

peripheral vitreochorioretinal dystrophy, macular dysfunction, ganzfeld ERG, multifocal ERG, laser coagulation

1. Robertson D. M., Norton E. W. Long-term follow-up of treated retinal breaks. Am J. Ophthalmol. 1973; 75 (3): 395–404. doi: 10.1016/0002-9394(73)91148-3

2. Algvere P.V., Jahnberg P., Textorius O. The Swedish Retinal Detachment Register, I: a database for epidemiological and clinical studies. Graefes. Arch. Clin. Exp. Ophthalmol. 1999; 237: 37–44. doi: 10.1007/s004170050208

3. Mitry D., Charteris D.G., Yorston D., et al. The epidemiology and socioeconomic associations of retinal detachment in Scotland: a two-year prospective population-based study. Invest. Ophthalmol. Vis. Sci. 2010; 51 (10): 4963–8. doi: 10.1167/iovs.10-5400

4. Lewis H. Peripheral retinal degenerations and the risk of retinal detachment. Am. J. Ophthalmol. 2003; 136 (1): 155–60. doi: 10.1016/s0002-9394(03)00144-2

5. Boyko E.V., Suetov A.A., Maltsev D.S. Lattice degeneration of the retina. Vestnik oftal'mologii. 2014; (2): 77–82 (in Russian).

6. Davis M.D. Natural history of retinal breaks without detachment. Arch. Ophthalmol. 1974; 92 (3): 183–94. doi: 10.1001/archopht.1974.01010010191001

7. Blindbaek S., Grauslund J. Prophylactic treatment of retinal breaks a systematic review. Acta Ophthalmol. 2014; 93 (1): 3–8. https://doi.org/10.1111/aos.12447

8. Conart J.B., Baron D., Berrod J.P. Degenerative lesions of the peripheral retina. J. Fr. Ophthalmol. 2014; 37 (1): 73–80. doi: 10.1016/j.jfo.2013.09.001

9. Hagler W.S., Woldoff H.S. Retinal detachment in relation to senile retinoschisis. Trans. Am. Acad. Ophthalmol. Otoloryngol. 1973; 77 (2): 99–113.

10. Byer N.E. Long-term natural history study of senile retinoschisis with implications for management. Ophthalmology. 1986; 93 (9): 1127–37. doi: 10.1016/s0161-6420(86)33601-7

11. Lukovskaya N.G., Astakhov Yu.S. Retinoschisis. Etiopathogenesis, diagnosis, clinic, treatment. Sankt-Peterburg; 2008 (in Russian).

12. Kanski J.J., Daniel R. Prophylaxis of retinal detachment. Am. J. Ophthalmol. 1975; 79 (2): 197–205. doi: 10.1016/0002-9394(75)90072-0

13. Kazahaya M. Prophylaxis of retinal detachment. Semin. Ophthalmology. 1995; 10 (1): 79–86. doi: 10.3109/08820539509059983

14. Meyer-Schwickerath G., Fried M. Prophylaxis of retinal detachment. Trans Ophthalmol. Soc. UK. 1980; 100 (Pt 1): 56–65.

15. Sacsonova E.O., Zakharova G.Yu., Platova L.A., et al. Prevention of retinal detachment in patients with peripheral vitreochorioretinal dystrophies. Oftal’mologicheskij zhurnal (Ukraine). 1983; (3): 151–4 (in Russian).

16. Adrean S.D., Eliott D., Detroit M.D. Prophylaxis for Retinal Detachment. Review of Ophthalmology. 2005. Published 2005. 15 (July). Available at https://www.reviewofophthalmology.com/article/prophylaxis-for-retinal-detachment

17. Liu C.-C., Liou S.-W., Woung L.-C. Long-Term results of laser photocoagulation for peripheral retinal pathologies in one teaching hospital of Taiwan. ARVO Annual Meeting Abstract. Invest. Ophthalmol. Vis. Sci. 2008; 49: 5224.

18. Velieva I.A., Ilyina T.S., Privivkova E.A., et al. The effectiveness of laser coagulation in the treatment of regmatogenous retinal detachment. Vestnik oftal'mologii. 2010; 5: 40–3 (in Russian).

19. Morkhat M.V., Marchenko L.N., Morkhat V.I. Preventive laser coagulation with changes in the peripheral parts of the retina (literature review). Ophthalmology. Eastern Europe (Minsk). 2011; 4 (11): 85–92 (in Russian).

20. Shaimova V.A. ed. Peripheral dystrophy of the retina. Optical coherence tomography. Laser retinal coagulation: atlas. Sankt-Petersburg; 2015 (in Russian).

21. Shaimov R.B., Shaimova V.A., Shaimov T. B., Galin A.Yu., Semenova L.E. Preventive laser coagulation of the retina in peripheral retinal ruptures (development of indications based on OCT results). Sovremennye tekhnologii lecheniya vitreoretinal'noj patologii. 2016; 1 (9): 238–40 (in Russian).

22. Verhoekx J.S.N., van Etten P.G., Wubbels R.J., van Meurs J.C., van Overdam K.A. Prophylactic laser treatment to decrease the incidence of retinal detachment in fellow eyes of idiopathic giant retinal tears. Retina. 2019 Mar 6. doi: 10.1097/IAE.0000000000002494

23. Bloome M.A., Garcia C.A. Manual of retina and choroidal dystrophies. AppletonCentury-Crofts: New York; 1982.

24. Avitabile T., Bonfiglio V., Reibaldi M., Torrisi B., Reibaldi A. Prophylactic treatment of the fellow eye of patients with retinal detachment: a retrospective study. Graefes Arch. Clin. Exp. Ophthalmol. 2004; 242 (3): 191–6. doi: 10.1007/s00417-003-0783-9

25. Bolshunov A.V., Ilyina T.S., Privivkova E.A. Laser prophylaxis and treatment of retinal detachments. In the book: A. Bolshunov, ed. Questions of laser ophthalmology. Moscow; 2013: 186–95 (in Russian).

26. Mukhtar A., Khan M.S., Junejo M., Ishaq M., Akbar B. Effect of pan retinal photocoagulation on central macular thickness and visual acuity in proliferative diabetic retinopathy. Pak. J. Med. Sci. 2016; 32 (1): 221–4. doi: http://dx.doi.org/10.12669/pjms.321.8758

27. Deschler E.K., Sun J.K., Silva P.S. Side-effects and complications of laser treatment in diabetic retinal disease. Semin. Ophthalmol. 2014; 29 (5–6): 290–300. doi: 10.3109/08820538.2014.959198

28. Henricsson M., Heijl A. The effect of panretinal laser photocoagulation on visual acuity, visual fields and on subjective visual impairment in preproliferative and early proliferative diabetic retinopathy. Acta Ophthalmol. (Copenh). 1994; 72 (5): 570–5. doi: 10.1111/j.1755-3768.1994.tb07181.x

29. Shimura M., Yasuda K., Nakazawa T., et al. Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy. Graefes Arch. Clin. Exp. Ophthalmol. 2009; 247 (12): 1617–24. doi: 10.1007/s00417-009-1147-x

30. Muqit M.M., Marcellino G.R., Henson D.B., Fenerty C.H., Stanga P.E. Randomized clinical trial to evaluate the effects of Pascal panretinal photocoagulation on macular nerve fiber layer: Manchester Pascal Study report 3. Retina. 2011; 31 (8): 1699–707. doi: 10.1097/IAE.0b013e318207d188

31. Muqit M.M., Young L.B., McKenzie R., et al. Pilot randomized clinical trial of Pascal Targeted Retinal versus variable fluence Panretinal 20ms laser in diabetic retinopathy: PETER PAN study. Br. J. Ophthalmol. 2013; 97 (2): 220–7. doi: 10.1136/bjophthalmol-2012-302189

32. Birch J., Hamilton A.M. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization: Part 2. Effect on colour vision. Trans Ophthalmol. Soc. UK. 1981; 101 (1): 93–9.

33. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991; 98 (5): 766–85.

34. Khosla P.K., Rao V., Tewari H.K., Kumar A. Contrast sensitivity in diabetic retinopathy after panretinal photocoagulation. Ophthalmic Surg. 1994; 25 (8): 516–20.

35. Higgins K.E., Meyers S.M., Jaffe M.J., et al. Temporary loss of foveal contrast sensitivity associated with panretinal photocoagulation. Arch. Ophthalmol. 1986; 104 (7): 997–1003. doi: 10.1001/archopht.1986.01050190055039

36. Lövestam-Adrian M., Svendenius N., Agardh E. Contrast sensitivity and visual recovery time in diabetic patients treated with panretinal photocoagulation. Acta Ophthalmol. Scand. 2000; 78 (6): 672–6. doi: 10.1034/j.16000420.2000.078006672.x

37. Neroev V.V., Tsapenko I.V., Zakharova G.Yu., Kondratyeva Yu.P., Zueva M.V. Change in the macular function of the paired eye in patients with regmatogenous retinal detachment and peripheral vitreochorioretinal dystrophies after laser retinal coagulation. Bulletin SB RAMN. 2014; 34 (3): 76–80 (in Russian).

38. McCulloch D.L., Marmor M.F., Brigell M.G., et al. ISCEV Standard for full-field clinical electroretinography (2015 update). Doc. Ophthalmol. 2015; 130: 1–12. doi:10.1007/s10633-014-9473-7

39. Hood D.C., Bach M., Brigell M., et al. ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc. Ophthalmol. 2012; 124: 1–13. doi: 10.1007/s10633-011-9296-8